Khiron Life Sciences Corp. (TSXV:KHRN, OTCQB:KHRNF), a cannabis company with core operations in Latin America announced today its financial results for the second quarter ended June 30, 2019. These filings are available for review on the Company’s SEDAR profile at www.sedar.com All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. […]
The post Khiron Life Sciences Reports Second Quarter Fiscal 2019 Financial Results appeared first on Technical420.
You may also like
-
Are These Safer Ways To Invest In Marijuana Stocks?
-
When Will Chuck Schumer Be Ready With His Cannabis Reform Bill?
-
Tilray Board of Directors Announces Approval of Amendment to Company’s Bylaws; Aphria and Tilray Announce Waiver of Charter Amendment Proposal Requirement
-
Best Marijuana Stock To Buy? Top Pot Stocks To Watch For Next Week
-
Tilray, Inc. (TLRY) Board of Directors Announces Approval of Amendment to Company’s Bylaws